Viewing StudyNCT02050529



Ignite Creation Date: 2024-05-06 @ 2:30 AM
Last Modification Date: 2024-10-26 @ 11:18 AM
Study NCT ID: NCT02050529
Status: COMPLETED
Last Update Posted: 2018-10-26
First Post: 2014-01-29

Brief Title: Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients
Sponsor: Dow University of Health Sciences
Organization: Dow University of Health Sciences

Conditions & Keywords Data

Conditions:
Name
Pre-eclampsia Superimposed Pre-existing Hypertension
Hypertension Pregnancy Induced
Hydralazine Adverse Reaction
Pre-eclampsia
Keywords:
Name View
Hydralazine View
Hypertension Pregnancy induced View
Pre-eclampsia View
Eclampsia View
Labetalol View